Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02749955 · ClinicalTrials.gov registry record · NA

Partner Services Pre-exposure Prophylaxis (PS-PrEP)

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
164
Enrollment target

NCT02749955 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 164 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02749955, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
164 participants
Enrollment target

Study Summary

This study evaluates the feasibility (reach, adoption, safety and implementation) and initial efficacy (higher linkage to care) of the Partner Services Pre-exposure Prophylaxis (PS-PrEP) intervention versus phone based Pre-exposure Prophylaxis (PrEP) treatment at 3 months post randomization among a sample of high risk individuals 18 - 35 years from clinic-based recruitment and internal referrals from social network based projects. The evaluation of the intervention will be used to strengthen routine department of public health services linkage to PrEP care.

Interventions

  • BEHAVIORAL PS-PrEP Intervention Group
  • BEHAVIORAL PrEPLine Control Group

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2015-11
Est. Completion 2018-07-30
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT02749955

The ClinicalTrials.gov registry entry for NCT02749955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which PS-PrEP Intervention Group is the first listed.

NCT02749955 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02749955 about?

NCT02749955 is a clinical study titled "Partner Services Pre-exposure Prophylaxis (PS-PrEP)". This study evaluates the feasibility (reach, adoption, safety and implementation) and initial efficacy (higher linkage to care) of the Partner Services Pre-exposure Prophylaxis (PS-PrEP) intervention versus phone based Pre-exposure Prophylaxis (PrEP) treatment at 3 months post randomization among a ...

What is the current status of trial NCT02749955?

This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2015-11. Estimated completion is 2018-07-30.

What interventions are being tested in trial NCT02749955?

The interventions under investigation include: PS-PrEP Intervention Group (BEHAVIORAL), PrEPLine Control Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02749955?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.